Patent · US Active

Chelated PSMA inhibitors

US10166301B2 · kind B2 · utility

1Cited by
3References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 17, 2018
Grant dateJan 1, 2019
Priority date—
Expiry dateJan 17, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/05
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds as defined herein are provided which are useful in (1) diagnostic methods for detecting and/or identifying cells presenting PSMA; (2) compositions comprising a compound of the invention together with a pharmaceutically acceptable diluent; and (3) methods for imaging prostate cancer cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.